Overview

SciFluor is the emerging leader in fluorine expertise and innovative fluorine technology. The company is strategically applying its expertise and proprietary fluorine technologies to accelerate the creation of innovative new medicines. SciFluor holds exclusive, worldwide rights to proprietary fluorine technology discovered at Harvard University in the Ritter Laboratory. Through an extended license with Harvard, the company also holds rights to technology that enables the rapid, efficient synthesis of novel 18F tracers that empower PET imaging for an entirely new level of intelligent, informed and predictive drug development. SciFluor is actively seeking industry partners for its collaborative model that aims to enrich its partners' drug development pipelines and ultimately improve patients' lives by developing innovative, fluorine-enhanced therapeutics.

Please visit SciFluor Life Sciences at www.scifluor.com